+1 #(S1 (S (NP (PRP We)) (VP (VBP propose) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ binds) (PP (TO to) (NP (NP (NP (JJ specific) (NN OT) (NNS receptors)) (PRN (-LRB- -LRB-) (NP (NN OTR)) (-RRB- -RRB-))) (PP (IN on) (NP (DT the) (NN endometrium) (S (VP (TO to) (VP (VB stimulate) (NP (JJ phosphoinositide) (-LRB- -LRB-) (NN PI) (-RRB- -RRB-) (NN hydrolysis))))))))) (, ,) (S (ADVP (RB thereby)) (VP (VBG activating) (NP (NP (NP (NP (DT the) (NN inositol) (NN trisphosphate)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (NN -diacylglycerol) (-LRB- -LRB-) (NN DAG) (-RRB- -RRB-) (NN second-messenger) (NN system)) (S (VP (TO to) (VP (VB promote) (NP (NN pulsatile) (NN PGF2) (NN alpha) (NN secretion))))))))))))))
+1 #(S1 (S (NP (JJ Endometrial) (NN _PROT1_)) (VP (VP (VBD was) (VP (VBN increased) (PP (IN within) (NP (CD 30) (NNS seconds))) (PP (IN after) (NP (NN _PROT2_) (NN treatment))))) (CC and) (VP (VBD preceded) (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NP (NN PGF2) (NN alpha) (NN release)) (VP (VBN stimulated) (PP (IN by) (NP (NN _PROT_)))))))))))
-1 #(S1 (S (NP (JJ Endometrial) (NN _PROT1_)) (VP (VP (VBD was) (VP (VBN increased) (PP (IN within) (NP (CD 30) (NNS seconds))) (PP (IN after) (NP (NN _PROT_) (NN treatment))))) (CC and) (VP (VBD preceded) (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NP (NN PGF2) (NN alpha) (NN release)) (VP (VBN stimulated) (PP (IN by) (NP (NN _PROT2_)))))))))))
-1 #(S1 (S (NP (JJ Endometrial) (NN _PROT_)) (VP (VP (VBD was) (VP (VBN increased) (PP (IN within) (NP (CD 30) (NNS seconds))) (PP (IN after) (NP (NN _PROT1_) (NN treatment))))) (CC and) (VP (VBD preceded) (NP (NP (DT the) (NN increase)) (PP (IN in) (NP (NP (NN PGF2) (NN alpha) (NN release)) (VP (VBN stimulated) (PP (IN by) (NP (NN _PROT2_)))))))))))
+1 #(S1 (S (NP (DT These) (NNS results)) (VP (VBP support) (NP (DT the) (NN hypothesis) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ stimulates) (NP (NN phospholipase) (NN C)) (S (VP (TO to) (VP (VB hydrolyze) (NP (NN PI))))))))) (, ,) (S (VP (VBG yielding) (NP (NP (NP (NP (NN _PROT2_)) (CC and) (NP (NN DAG))) (NNS second-messengers)) (SBAR (WHNP (WDT which)) (S (VP (VBP promote) (NP (NP (JJ endometrial) (NN PGF2) (NN alpha)) (NN release)) (PP (IN during) (NP (NP (NN CL) (NN regression)) (PP (IN in) (NP (NNS pigs))))))))))))))
-1 #(S1 (S (S (NP (DT The) (VBG resulting) (ADJP (RB abnormally) (VBN phosphorylated)) (NN _PROT1_)) (VP (VBZ aggregates) (PP (TO to) (NP (ADJP (RB freshly) (VBN synthesized)) (NN _PROT2_))) (, ,) (S (VP (VBG transforming) (NP (PRP it)) (PP (IN into) (NP (JJ same))) (: ;) (PP (IN due) (TO to) (NP (NP (DT a) (NN system)) (PP (IN of) (NP (NP (JJ positive) (NN feedback)) (VP (VBN invoked) (PP (IN by) (NP (NP (DT the) (JJ organophosphate-induced) (NN blockage)) (PP (IN of) (NP (DT a) (NN _PROT_) (JJ _PROT_) (NN _PROT_) (NN _PROT_)))))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (VBG resulting) (ADJP (RB abnormally) (VBN phosphorylated)) (NN _PROT1_)) (VP (VBZ aggregates) (PP (TO to) (NP (ADJP (RB freshly) (VBN synthesized)) (NN _PROT_))) (, ,) (S (VP (VBG transforming) (NP (PRP it)) (PP (IN into) (NP (JJ same))) (: ;) (PP (IN due) (TO to) (NP (NP (DT a) (NN system)) (PP (IN of) (NP (NP (JJ positive) (NN feedback)) (VP (VBN invoked) (PP (IN by) (NP (NP (DT the) (JJ organophosphate-induced) (NN blockage)) (PP (IN of) (NP (DT a) (NN _PROT2_) (JJ _PROT2_) (NN _PROT_) (NN _PROT_)))))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (VBG resulting) (ADJP (RB abnormally) (VBN phosphorylated)) (NN _PROT1_)) (VP (VBZ aggregates) (PP (TO to) (NP (ADJP (RB freshly) (VBN synthesized)) (NN _PROT_))) (, ,) (S (VP (VBG transforming) (NP (PRP it)) (PP (IN into) (NP (JJ same))) (: ;) (PP (IN due) (TO to) (NP (NP (DT a) (NN system)) (PP (IN of) (NP (NP (JJ positive) (NN feedback)) (VP (VBN invoked) (PP (IN by) (NP (NP (DT the) (JJ organophosphate-induced) (NN blockage)) (PP (IN of) (NP (DT a) (NN _PROT_) (JJ _PROT_) (NN _PROT2_) (NN _PROT2_)))))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (VBG resulting) (ADJP (RB abnormally) (VBN phosphorylated)) (NN _PROT_)) (VP (VBZ aggregates) (PP (TO to) (NP (ADJP (RB freshly) (VBN synthesized)) (NN _PROT1_))) (, ,) (S (VP (VBG transforming) (NP (PRP it)) (PP (IN into) (NP (JJ same))) (: ;) (PP (IN due) (TO to) (NP (NP (DT a) (NN system)) (PP (IN of) (NP (NP (JJ positive) (NN feedback)) (VP (VBN invoked) (PP (IN by) (NP (NP (DT the) (JJ organophosphate-induced) (NN blockage)) (PP (IN of) (NP (DT a) (NN _PROT2_) (JJ _PROT2_) (NN _PROT_) (NN _PROT_)))))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (VBG resulting) (ADJP (RB abnormally) (VBN phosphorylated)) (NN _PROT_)) (VP (VBZ aggregates) (PP (TO to) (NP (ADJP (RB freshly) (VBN synthesized)) (NN _PROT1_))) (, ,) (S (VP (VBG transforming) (NP (PRP it)) (PP (IN into) (NP (JJ same))) (: ;) (PP (IN due) (TO to) (NP (NP (DT a) (NN system)) (PP (IN of) (NP (NP (JJ positive) (NN feedback)) (VP (VBN invoked) (PP (IN by) (NP (NP (DT the) (JJ organophosphate-induced) (NN blockage)) (PP (IN of) (NP (DT a) (NN _PROT_) (JJ _PROT_) (NN _PROT2_) (NN _PROT2_)))))))))))))) (. .)))
+1 #(S1 (S (S (NP (DT The) (VBG resulting) (ADJP (RB abnormally) (VBN phosphorylated)) (NN _PROT_)) (VP (VBZ aggregates) (PP (TO to) (NP (ADJP (RB freshly) (VBN synthesized)) (NN _PROT_))) (, ,) (S (VP (VBG transforming) (NP (PRP it)) (PP (IN into) (NP (JJ same))) (: ;) (PP (IN due) (TO to) (NP (NP (DT a) (NN system)) (PP (IN of) (NP (NP (JJ positive) (NN feedback)) (VP (VBN invoked) (PP (IN by) (NP (NP (DT the) (JJ organophosphate-induced) (NN blockage)) (PP (IN of) (NP (DT a) (NN _PROT1_) (JJ _PROT1_) (NN _PROT2_) (NN _PROT2_)))))))))))))) (. .)))
+1 #(S1 (S (NP (NN _PROT1_)) (VP (MD may) (ADVP (RB rapidly)) (VP (VB stimulate) (NP (NP (ADJP (NN _PROT2_) (-LRB- _PROT2_) (NN _PROT2_) (-RRB- _PROT2_) (JJ _PROT2_) (PRN (-LRB- -LRB-) (NP (NN IP3)) (-RRB- -RRB-)))) (CC and) (NP (NP (NN diacylglycerol)) (PRN (-LRB- -LRB-) (NP (NN DAG)) (-RRB- -RRB-))) (NP (NN formation))) (, ,) (S (ADJP (JJ consistent) (PP (IN with) (NP (NP (DT the) (NN concept)) (PP (IN of) (NP (NP (JJ rapid) (NN activation)) (PP (IN of) (NP (DT a) (NN second-messenger) (NN system)))))))))))))
+1 #(S1 (S (PP (IN In) (NP (NP (NN support)) (PP (IN of) (NP (DT this) (NN hypothesis))))) (, ,) (NP (JJ endometrial) (NN _PROT1_) (NNS levels)) (VP (VBD were) (VP (VBN increased) (PRN (-LRB- -LRB-) (NP (NN P) (NN <) (CD 0.05)) (-RRB- -RRB-)) (PP (IN within) (NP (CD 0.5) (NN min))) (PP (IN after) (NP (NP (NN treatment)) (PP (IN with) (NP (ADJP (CD 0.1) (NN microM)) (NN _PROT2_)))))))))
+1 #(S1 (S (NP (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ induces) (NP (JJ endometrial) (NN _PROT2_) (NN production)) (PP (IN in) (NP (NP (DT a) (JJ rapid) (NN manner)) (ADJP (JJ indicative) (PP (IN of) (NP (DT a) (NN second-messenger) (NN system))))))))))))
-1 #(S1 (S (S (LST (LS 2) (-RRB- -RRB-)) (NP (NP (NN IGF-1)) (, ,) (NP (NN IGF-2)) (, ,) (CC and) (NP (NN _PROT1_))) (ADVP (RB also)) (VP (VBD induced) (NP (NP (DT a) (NN Ca2+) (NN mobilization)) (PP (IN from) (NP (DT the) (JJ endoplasmic) (NN reticulum)))))) (: :) (S (NP (NP (NP (NP (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN PLC)) (-RRB- -RRB-))) (NNS inhibitors)) (, ,) (NP (NN neomycin)) (, ,) (CC or) (NP (NN U-73122))) (VP (VP (ADVP (RB partially)) (VBD blocked) (NP (NP (DT the) (JJ intracellular) (NN [Ca2+) (-RRB- -RSB-) (NN i) (NN increase)) (VP (VBN induced) (PP (IN by) (NP (NP (NN IGF-1)) (CC and) (NP (NN _PROT_))))))) (CC and) (VP (ADVP (RB totally)) (VBD inhibited) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN IGF-2)))))))))
-1 #(S1 (S (S (LST (LS 2) (-RRB- -RRB-)) (NP (NP (NN IGF-1)) (, ,) (NP (NN IGF-2)) (, ,) (CC and) (NP (NN _PROT1_))) (ADVP (RB also)) (VP (VBD induced) (NP (NP (DT a) (NN Ca2+) (NN mobilization)) (PP (IN from) (NP (DT the) (JJ endoplasmic) (NN reticulum)))))) (: :) (S (NP (NP (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN PLC)) (-RRB- -RRB-))) (NNS inhibitors)) (, ,) (NP (NN neomycin)) (, ,) (CC or) (NP (NN U-73122))) (VP (VP (ADVP (RB partially)) (VBD blocked) (NP (NP (DT the) (JJ intracellular) (NN [Ca2+) (-RRB- -RSB-) (NN i) (NN increase)) (VP (VBN induced) (PP (IN by) (NP (NP (NN IGF-1)) (CC and) (NP (NN _PROT2_))))))) (CC and) (VP (ADVP (RB totally)) (VBD inhibited) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN IGF-2)))))))))
+1 #(S1 (S (S (LST (LS 2) (-RRB- -RRB-)) (NP (NP (NN IGF-1)) (, ,) (NP (NN IGF-2)) (, ,) (CC and) (NP (NN _PROT_))) (ADVP (RB also)) (VP (VBD induced) (NP (NP (DT a) (NN Ca2+) (NN mobilization)) (PP (IN from) (NP (DT the) (JJ endoplasmic) (NN reticulum)))))) (: :) (S (NP (NP (NP (NP (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN PLC)) (-RRB- -RRB-))) (NNS inhibitors)) (, ,) (NP (NN neomycin)) (, ,) (CC or) (NP (NN U-73122))) (VP (VP (ADVP (RB partially)) (VBD blocked) (NP (NP (DT the) (JJ intracellular) (NN [Ca2+) (-RRB- -RSB-) (NN i) (NN increase)) (VP (VBN induced) (PP (IN by) (NP (NP (NN IGF-1)) (CC and) (NP (NN _PROT2_))))))) (CC and) (VP (ADVP (RB totally)) (VBD inhibited) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN IGF-2)))))))))
+1 #(S1 (S (NP (NN _PROT1_)) (VP (VBZ increases) (NP (NP (NN _PROT2_) (NN _PROT2_) (NN expression)) (CC and) (NP (NN energy) (NN expenditure))))))
+1 #(S1 (S (NP (NN _PROT1_)) (VP (VBD increased) (NP (NN BAT) (NN _PROT2_) (NN mRNA) (NNS levels)) (NP (JJR greater) (IN than) (RB twofold)) (PP (IN in) (NP (DT both) (NN ad) (JJ libitum-fed) (CC and) (JJ food-restricted) (NNS rats))))))
-1 #(S1 (S (NP (DT These) (NNS data)) (VP (VP (VBP demonstrate) (NP (NP (DT a) (JJ _PROT1_) (NN increase)) (PP (IN in) (NP (NN energy) (NN expenditure))) (PP (IN in) (NP (JJ nonmutant) (NNS rodents))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (CD one) (NN mechanism)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NN _PROT2_)) (VP (VBZ increases) (NP (NN energy) (NN expenditure)))))) (VP (VBZ is) (PP (IN through) (NP (NP (VBN increased) (NN thermogenesis)) (PP (IN in) (NP (NN BAT))))) (, ,) (S (VP (VBG including) (NP (NP (VBN increased) (NN expression)) (PP (IN of) (NP (NN _PROT_)))))))))))))
-1 #(S1 (S (NP (DT These) (NNS data)) (VP (VP (VBP demonstrate) (NP (NP (DT a) (JJ _PROT1_) (NN increase)) (PP (IN in) (NP (NN energy) (NN expenditure))) (PP (IN in) (NP (JJ nonmutant) (NNS rodents))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (CD one) (NN mechanism)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NN _PROT_)) (VP (VBZ increases) (NP (NN energy) (NN expenditure)))))) (VP (VBZ is) (PP (IN through) (NP (NP (VBN increased) (NN thermogenesis)) (PP (IN in) (NP (NN BAT))))) (, ,) (S (VP (VBG including) (NP (NP (VBN increased) (NN expression)) (PP (IN of) (NP (NN _PROT2_)))))))))))))
+1 #(S1 (S (NP (DT These) (NNS data)) (VP (VP (VBP demonstrate) (NP (NP (DT a) (JJ _PROT_) (NN increase)) (PP (IN in) (NP (NN energy) (NN expenditure))) (PP (IN in) (NP (JJ nonmutant) (NNS rodents))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (CD one) (NN mechanism)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NN _PROT1_)) (VP (VBZ increases) (NP (NN energy) (NN expenditure)))))) (VP (VBZ is) (PP (IN through) (NP (NP (VBN increased) (NN thermogenesis)) (PP (IN in) (NP (NN BAT))))) (, ,) (S (VP (VBG including) (NP (NP (VBN increased) (NN expression)) (PP (IN of) (NP (NN _PROT2_)))))))))))))
+1 #(S1 (S (NP (NN _PROT1_) (NN _PROT1_)) (VP (VBZ is) (NP (NP (DT a) (NN mediator)) (PP (IN of) (NP (NP (NNS thermogenesis)) (VP (VBN regulated) (PP (IN by) (NP (NP (NN thyroid) (NN hormone)) (, ,) (NP (JJ beta3-adrenergic) (NNS agonists)) (, ,) (CC and) (NP (NN _PROT2_)))))))))))
+1 #(S1 (S (NP (NN _PROT1_) (NN mRNA) (NNS levels)) (VP (VBD were) (ADVP (RB also)) (VP (VBN regulated) (PP (IN by) (NP (NP (NN dexamethasone)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN starvation))))) (, ,) (SBAR (IN albeit) (FRAG (RB differently) (PP (IN in) (NP (NP (NN muscle)) (CC and) (NP (JJ brown) (NN adipose) (NN tissue)))))))))
-1 #(S1 (S (NP (NP (NN PKB)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (DT an) (JJ important) (JJ early) (NN PI) (NN 3-kinase-dependent) (NN component)) (PP (IN of) (NP (NN _PROT1_) (NN signalling) (NNS pathways))))))) (, ,)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN down-regulated) (PP (IN by) (NP (JJ _PROT2_) (NNS agonists)))))))
+1 #(S1 (S (NP (NP (JJ Secreted) (NN form)) (PP (IN of) (NP (NN _PROT1_) (NN precursor) (NN protein)))) (VP (VBZ activates) (NP (NP (NP (NN protein) (NN kinase) (NN C)) (CC and) (NP (NN _PROT2_) (NN _PROT2_))) (PP (IN in) (NP (VBN cultured) (JJ embryonic) (NN rat) (JJ neocortical) (NNS cells)))))))
+1 #(S1 (S (ADVP (RB Furthermore)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT1_) (NN _PROT1_)))) (CC and) (NP (NP (NN formation)) (PP (IN of) (NP (NN inositol) (NN 1,4,5-trisphosphate))))) (VP (VBD were) (VP (VBN increased) (PP (IN by) (NP (NN _PROT2_))))))))))
+1 #(S1 (S (S (VP (TO To) (VP (VB assess) (NP (NP (DT the) (JJ possible) (NN involvement)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN in) (NP (NP (NN _PROT2_)) (CC and) (NP (NN IL-1) (NN action)))) (PP (IN in) (NP (NN Leydig) (NNS cells))))))) (, ,) (NP (DT the) (NN _PROT_) (NN inhibitor) (NN Calphostin) (NN C)) (VP (VBD was) (VP (VBN tested)))))
-1 #(S1 (S (S (VP (TO To) (VP (VB assess) (NP (NP (DT the) (JJ possible) (NN involvement)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN in) (NP (NP (NN _PROT_)) (CC and) (NP (NN IL-1) (NN action)))) (PP (IN in) (NP (NN Leydig) (NNS cells))))))) (, ,) (NP (DT the) (NN _PROT2_) (NN inhibitor) (NN Calphostin) (NN C)) (VP (VBD was) (VP (VBN tested)))))
-1 #(S1 (S (S (VP (TO To) (VP (VB assess) (NP (NP (DT the) (JJ possible) (NN involvement)) (PP (IN of) (NP (NN _PROT_))) (PP (IN in) (NP (NP (NN _PROT1_)) (CC and) (NP (NN IL-1) (NN action)))) (PP (IN in) (NP (NN Leydig) (NNS cells))))))) (, ,) (NP (DT the) (NN _PROT2_) (NN inhibitor) (NN Calphostin) (NN C)) (VP (VBD was) (VP (VBN tested)))))
+1 #(S1 (S (NP (DT These) (NNS results)) (VP (VP (VBP confirm) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN PMA))) (VP (VBP activate) (NP (NN _PROT2_)))))) (CC and) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN IL-1)) (ADVP (RB likely)) (VP (VBZ does) (RB not) (VP (VB activate) (NP (NN _PROT_)) (PP (IN in) (NP (NN Leydig) (NNS cells)))))))))))
-1 #(S1 (S (NP (DT These) (NNS results)) (VP (VP (VBP confirm) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN PMA))) (VP (VBP activate) (NP (NN _PROT_)))))) (CC and) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN IL-1)) (ADVP (RB likely)) (VP (VBZ does) (RB not) (VP (VB activate) (NP (NN _PROT2_)) (PP (IN in) (NP (NN Leydig) (NNS cells)))))))))))
-1 #(S1 (S (NP (DT These) (NNS results)) (VP (VP (VBP confirm) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NN PMA))) (VP (VBP activate) (NP (NN _PROT1_)))))) (CC and) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN IL-1)) (ADVP (RB likely)) (VP (VBZ does) (RB not) (VP (VB activate) (NP (NN _PROT2_)) (PP (IN in) (NP (NN Leydig) (NNS cells)))))))))))
+1 #(S1 (S (SBAR (IN If) (S (NP (JJ daily) (NN _PROT1_) (NNS injections)) (VP (VBP are) (VP (VBN repeated) (PP (IN over) (NP (DT a) (JJ 5-day) (NN period))))))) (, ,) (S (S (NP (NN blood) (NN pressure)) (VP (VBZ is) (VP (VBN decreased) (PP (IN by) (NP (CD 10-20) (NN mmHg)))))) (, ,) (S (NP (NP (DT the) (NN withdrawal) (NN latency)) (PP (TO to) (NP (NN heat) (NNS stimuli)))) (VP (VBZ is) (ADJP (JJ prolonged)))) (, ,) (S (NP (NN cortisol) (NNS levels)) (VP (VBP are) (VP (VBN decreased)))) (CC and) (S (NP (NP (NP (NN _PROT2_)) (CC and) (NP (NN cholecystokinin))) (NNS levels)) (VP (VBP are) (VP (VBN increased)))))))
+1 #(S1 (S (S (NP (NP (NN Fasting)) (CC and) (NP (NN _PROT1_))) (VP (VBP modulate) (NP (NP (NN adipose)) (CC and) (NP (NN muscle) (NN _PROT2_) (NN _PROT2_))))) (: :) (NP (NP (JJ divergent) (NNS effects)) (PP (IN between) (NP (NP (NN messenger) (JJ ribonucleic) (NN acid)) (CC and) (NP (NN protein) (NN expression)))))))
-1 #(S1 (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBD examined) (NP (NP (DT the) (NNS effects)) (PP (IN of) (NP (NP (NP (NN fasting)) (PP (IN for) (NP (CD 2) (NNS days)))) (CC and) (NP (NP (JJ exogenous) (NN s.c.) (NN _PROT1_)) (, ,) (NP (NP (ADJP (CD 200) (NN microg)) (DT every) (CD 8) (NN h)) (PP (IN for) (NP (CD 2) (NNS days)))) (, ,)))) (PP (IN on) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (NP (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN UCP)) (-RRB- -RRB-))) (NNS subtypes)))))) (PP (IN in) (NP (NP (NP (JJ brown) (NN adipose) (NN tissue)) (PRN (-LRB- -LRB-) (NP (NN BAT)) (-RRB- -RRB-))) (CC and) (NP (JJ gastrocnemius) (NN muscle)))))))
-1 #(S1 (S (NP (NN _PROT1_)) (, ,) (PP (VBN compared) (PP (IN with) (NP (NN vehicle)))) (, ,) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (NN BAT) (NN _PROT2_)) (CC or) (NP (NN _PROT_) (NN mRNA)) (CC or) (NP (NN protein) (NN expression)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (TO to) (NP (JJ normal) (ADJP (NN ad) (NN libitum) (JJ fed)) (NNS rats)))))))))
-1 #(S1 (S (NP (NN _PROT1_)) (, ,) (PP (VBN compared) (PP (IN with) (NP (NN vehicle)))) (, ,) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (NN BAT) (NN _PROT_)) (CC or) (NP (NN _PROT2_) (NN mRNA)) (CC or) (NP (NN protein) (NN expression)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (TO to) (NP (JJ normal) (ADJP (NN ad) (NN libitum) (JJ fed)) (NNS rats)))))))))
-1 #(S1 (S (NP (NN _PROT_)) (, ,) (PP (VBN compared) (PP (IN with) (NP (NN vehicle)))) (, ,) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (NN BAT) (NN _PROT1_)) (CC or) (NP (NN _PROT2_) (NN mRNA)) (CC or) (NP (NN protein) (NN expression)))) (SBAR (WHADVP (WRB when)) (S (VP (VBN administered) (PP (TO to) (NP (JJ normal) (ADJP (NN ad) (NN libitum) (JJ fed)) (NNS rats)))))))))
-1 #(S1 (S (NP (NN Fasting)) (ADVP (RB significantly)) (VP (VBD decreased) (NP (NN BAT) (NN _PROT1_) (CC and) (NN _PROT2_) (NN mRNA) (NN expression)) (, ,) (PP (TO to) (NP (NP (NP (CD 31) (NN %)) (CC and) (NP (CD 30) (NN %))) (PP (IN of) (NP (ADJP (NN ad) (NN libitum) (JJ fed)) (NNS controls))))) (, ,) (ADVP (RB respectively)) (, ,) (NP (NP (NNS effects)) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (VP (VBN prevented) (PP (IN by) (NP (NP (NN administration)) (PP (IN of) (NP (NN _PROT_))) (PP (TO to) (NP (JJ fasted) (NNS rats)))))))))))))
+1 #(S1 (S (NP (NN Fasting)) (ADVP (RB significantly)) (VP (VBD decreased) (NP (NN BAT) (NN _PROT1_) (CC and) (NN _PROT_) (NN mRNA) (NN expression)) (, ,) (PP (TO to) (NP (NP (NP (CD 31) (NN %)) (CC and) (NP (CD 30) (NN %))) (PP (IN of) (NP (ADJP (NN ad) (NN libitum) (JJ fed)) (NNS controls))))) (, ,) (ADVP (RB respectively)) (, ,) (NP (NP (NNS effects)) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (VP (VBN prevented) (PP (IN by) (NP (NP (NN administration)) (PP (IN of) (NP (NN _PROT2_))) (PP (TO to) (NP (JJ fasted) (NNS rats)))))))))))))
+1 #(S1 (S (NP (NN Fasting)) (ADVP (RB significantly)) (VP (VBD decreased) (NP (NN BAT) (NN _PROT_) (CC and) (NN _PROT1_) (NN mRNA) (NN expression)) (, ,) (PP (TO to) (NP (NP (NP (CD 31) (NN %)) (CC and) (NP (CD 30) (NN %))) (PP (IN of) (NP (ADJP (NN ad) (NN libitum) (JJ fed)) (NNS controls))))) (, ,) (ADVP (RB respectively)) (, ,) (NP (NP (NNS effects)) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (VP (VBN prevented) (PP (IN by) (NP (NP (NN administration)) (PP (IN of) (NP (NN _PROT2_))) (PP (TO to) (NP (JJ fasted) (NNS rats)))))))))))))
-1 #(S1 (S (S (NP (NN Fasting)) (ADVP (RB also)) (VP (ADVP (RB significantly)) (VBD decreased) (NP (NN BAT) (NN _PROT1_) (NN protein) (NN expression)) (, ,) (PP (TO to) (NP (NP (CD 67) (NN %)) (PP (IN of) (NP (NN control))))))) (: ;) (S (ADVP (RB however)) (, ,) (NP (DT that) (NN effect)) (VP (VBD was) (RB not) (VP (VBN prevented) (PP (IN by) (NP (NN _PROT2_) (NN treatment))))))))
-1 #(S1 (S (S (NP (NP (NN Fasting)) (, ,) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (NN _PROT1_) (NN administration)))) (, ,)) (VP (VBD did) (RB not) (VP (VB affect) (NP (NN BAT) (NN _PROT2_) (NN mRNA))))) (: ;) (ADVP (RB however)) (, ,) (S (NP (NP (JJ _PROT_) (NN administration)) (PP (TO to) (NP (ADJP (NN ad) (NN libitum) (JJ fed)) (NNS rats)))) (ADVP (RB significantly)) (VP (VBD increased) (NP (NN BAT) (NN _PROT_) (NN mRNA)) (, ,) (PP (TO to) (NP (NP (CD 138) (NN %)) (PP (IN of) (NP (NN control)))))))))
-1 #(S1 (S (S (NP (NP (NN Fasting)) (, ,) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (NN _PROT1_) (NN administration)))) (, ,)) (VP (VBD did) (RB not) (VP (VB affect) (NP (NN BAT) (NN _PROT_) (NN mRNA))))) (: ;) (ADVP (RB however)) (, ,) (S (NP (NP (JJ _PROT2_) (NN administration)) (PP (TO to) (NP (ADJP (NN ad) (NN libitum) (JJ fed)) (NNS rats)))) (ADVP (RB significantly)) (VP (VBD increased) (NP (NN BAT) (NN _PROT_) (NN mRNA)) (, ,) (PP (TO to) (NP (NP (CD 138) (NN %)) (PP (IN of) (NP (NN control)))))))))
-1 #(S1 (S (S (NP (NP (NN Fasting)) (, ,) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (NN _PROT1_) (NN administration)))) (, ,)) (VP (VBD did) (RB not) (VP (VB affect) (NP (NN BAT) (NN _PROT_) (NN mRNA))))) (: ;) (ADVP (RB however)) (, ,) (S (NP (NP (JJ _PROT_) (NN administration)) (PP (TO to) (NP (ADJP (NN ad) (NN libitum) (JJ fed)) (NNS rats)))) (ADVP (RB significantly)) (VP (VBD increased) (NP (NN BAT) (NN _PROT2_) (NN mRNA)) (, ,) (PP (TO to) (NP (NP (CD 138) (NN %)) (PP (IN of) (NP (NN control)))))))))
-1 #(S1 (S (S (NP (NP (NN Fasting)) (, ,) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (NN _PROT_) (NN administration)))) (, ,)) (VP (VBD did) (RB not) (VP (VB affect) (NP (NN BAT) (NN _PROT1_) (NN mRNA))))) (: ;) (ADVP (RB however)) (, ,) (S (NP (NP (JJ _PROT2_) (NN administration)) (PP (TO to) (NP (ADJP (NN ad) (NN libitum) (JJ fed)) (NNS rats)))) (ADVP (RB significantly)) (VP (VBD increased) (NP (NN BAT) (NN _PROT_) (NN mRNA)) (, ,) (PP (TO to) (NP (NP (CD 138) (NN %)) (PP (IN of) (NP (NN control)))))))))
-1 #(S1 (S (S (NP (NP (NN Fasting)) (, ,) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (NN _PROT_) (NN administration)))) (, ,)) (VP (VBD did) (RB not) (VP (VB affect) (NP (NN BAT) (NN _PROT1_) (NN mRNA))))) (: ;) (ADVP (RB however)) (, ,) (S (NP (NP (JJ _PROT_) (NN administration)) (PP (TO to) (NP (ADJP (NN ad) (NN libitum) (JJ fed)) (NNS rats)))) (ADVP (RB significantly)) (VP (VBD increased) (NP (NN BAT) (NN _PROT2_) (NN mRNA)) (, ,) (PP (TO to) (NP (NP (CD 138) (NN %)) (PP (IN of) (NP (NN control)))))))))
+1 #(S1 (S (S (NP (NP (NN Fasting)) (, ,) (PP (PP (IN with)) (CC or) (PP (IN without) (NP (NN _PROT_) (NN administration)))) (, ,)) (VP (VBD did) (RB not) (VP (VB affect) (NP (NN BAT) (NN _PROT_) (NN mRNA))))) (: ;) (ADVP (RB however)) (, ,) (S (NP (NP (JJ _PROT1_) (NN administration)) (PP (TO to) (NP (ADJP (NN ad) (NN libitum) (JJ fed)) (NNS rats)))) (ADVP (RB significantly)) (VP (VBD increased) (NP (NN BAT) (NN _PROT2_) (NN mRNA)) (, ,) (PP (TO to) (NP (NP (CD 138) (NN %)) (PP (IN of) (NP (NN control)))))))))
-1 #(S1 (S (NP (NN Fasting)) (ADVP (RB significantly)) (VP (VBD enhanced) (NP (NP (NP (JJ gastrocnemius) (NN muscle) (NN _PROT1_) (NN mRNA)) (PRN (-LRB- -LRB-) (NP (NP (CD 411) (NN %)) (PP (IN of) (NP (NN control)))) (-RRB- -RRB-))) (CC and) (NP (NP (NN protein) (NN expression)) (PRN (-LRB- -LRB-) (NP (NP (CD 168) (NN %)) (PP (IN of) (NP (NN control)))) (-RRB- -RRB-)))) (, ,) (SBAR (IN whereas) (S (NP (NP (JJ _PROT2_) (NN administration)) (PP (TO to) (NP (JJ fasted) (NNS rats)))) (VP (VBD did) (RB not) (VP (VB alter) (NP (NP (DT either)) (PP (IN of) (NP (DT these) (NNS effects)))))))))))
+1 #(S1 (S (PP (IN In) (NP (NN summary))) (, ,) (NP (NP (NN _PROT1_) (NN subtype) (NN mRNA)) (CC and) (NP (NN protein))) (VP (VBP are) (VP (VBN regulated) (PP (IN in) (NP (NP (NN tissue-)) (CC and) (NP (NN subtype-specific)) (NP (NN fashion)))) (PP (IN by) (NP (NP (NN _PROT2_)) (CC and) (NP (NN food) (NN restriction))))))))
+1 #(S1 (S (PP (IN In) (NP (JJ normal) (JJ pancreatic) (NNS islets))) (, ,) (NP (NN _PROT1_)) (VP (VP (VBZ is) (VP (VBN upregulated) (PP (IN by) (NP (NN _PROT2_))))) (CC and) (VP (VBZ is) (ADJP (JJ low) (PP (IN in) (NP (NP (JJ _PROT_) (NNS islets)) (PP (IN of) (NP (NN ZDF) (NNS rats))))))))))
-1 #(S1 (S (PP (IN In) (NP (JJ normal) (JJ pancreatic) (NNS islets))) (, ,) (NP (NN _PROT1_)) (VP (VP (VBZ is) (VP (VBN upregulated) (PP (IN by) (NP (NN _PROT_))))) (CC and) (VP (VBZ is) (ADJP (JJ low) (PP (IN in) (NP (NP (JJ _PROT2_) (NNS islets)) (PP (IN of) (NP (NN ZDF) (NNS rats))))))))))
-1 #(S1 (S (PP (IN In) (NP (JJ normal) (JJ pancreatic) (NNS islets))) (, ,) (NP (NN _PROT_)) (VP (VP (VBZ is) (VP (VBN upregulated) (PP (IN by) (NP (NN _PROT1_))))) (CC and) (VP (VBZ is) (ADJP (JJ low) (PP (IN in) (NP (NP (JJ _PROT2_) (NNS islets)) (PP (IN of) (NP (NN ZDF) (NNS rats))))))))))
-1 #(S1 (S (VP (TO To) (VP (VB determine) (SBAR (SBAR (IN whether) (S (NP (NN _PROT1_)) (VP (VBZ does) (, ,) (PP (IN in) (NP (NN fact))) (, ,) (VP (VB have) (NP (NN uncoupling) (NN activity)))))) (CC and) (, ,) (SBAR (IN if) (S (ADVP (RB so)) (, ,) (SBAR (IN whether) (S (NP (JJ such) (NN activity)) (VP (MD would) (ADVP (RB favorably)) (VP (VB influence) (NP (NP (DT the) (NNS abnormalities)) (PP (IN in) (NP (NP (JJ _PROT2_) (JJ _PROT_) (NNS islets)) (PP (IN of) (NP (JJ diabetic) (NN ZDF) (NNS rats)))))))))) (, ,) (NP (PRP we)) (VP (VBN transferred) (NP (DT the) (NN _PROT_) (NN gene)) (PP (TO to) (NP (NP (DT the) (NNS islets)) (PP (IN of) (NP (NP (JJ diabetic) (NN ZDF) (NNS rats)) (CC and) (NP (ADJP (ADJP (JJ lean)) (PRN (-LRB- -LRB-) (NP (NN +/+)) (-RRB- -RRB-))) (NN ZDF) (NN control) (NNS rats))))))))))))))
-1 #(S1 (S (VP (TO To) (VP (VB determine) (SBAR (SBAR (IN whether) (S (NP (NN _PROT1_)) (VP (VBZ does) (, ,) (PP (IN in) (NP (NN fact))) (, ,) (VP (VB have) (NP (NN uncoupling) (NN activity)))))) (CC and) (, ,) (SBAR (IN if) (S (ADVP (RB so)) (, ,) (SBAR (IN whether) (S (NP (JJ such) (NN activity)) (VP (MD would) (ADVP (RB favorably)) (VP (VB influence) (NP (NP (DT the) (NNS abnormalities)) (PP (IN in) (NP (NP (JJ _PROT_) (JJ _PROT2_) (NNS islets)) (PP (IN of) (NP (JJ diabetic) (NN ZDF) (NNS rats)))))))))) (, ,) (NP (PRP we)) (VP (VBN transferred) (NP (DT the) (NN _PROT_) (NN gene)) (PP (TO to) (NP (NP (DT the) (NNS islets)) (PP (IN of) (NP (NP (JJ diabetic) (NN ZDF) (NNS rats)) (CC and) (NP (ADJP (ADJP (JJ lean)) (PRN (-LRB- -LRB-) (NP (NN +/+)) (-RRB- -RRB-))) (NN ZDF) (NN control) (NNS rats))))))))))))))
-1 #(S1 (S (VP (TO To) (VP (VB determine) (SBAR (SBAR (IN whether) (S (NP (NN _PROT1_)) (VP (VBZ does) (, ,) (PP (IN in) (NP (NN fact))) (, ,) (VP (VB have) (NP (NN uncoupling) (NN activity)))))) (CC and) (, ,) (SBAR (IN if) (S (ADVP (RB so)) (, ,) (SBAR (IN whether) (S (NP (JJ such) (NN activity)) (VP (MD would) (ADVP (RB favorably)) (VP (VB influence) (NP (NP (DT the) (NNS abnormalities)) (PP (IN in) (NP (NP (JJ _PROT_) (JJ _PROT_) (NNS islets)) (PP (IN of) (NP (JJ diabetic) (NN ZDF) (NNS rats)))))))))) (, ,) (NP (PRP we)) (VP (VBN transferred) (NP (DT the) (NN _PROT2_) (NN gene)) (PP (TO to) (NP (NP (DT the) (NNS islets)) (PP (IN of) (NP (NP (JJ diabetic) (NN ZDF) (NNS rats)) (CC and) (NP (ADJP (ADJP (JJ lean)) (PRN (-LRB- -LRB-) (NP (NN +/+)) (-RRB- -RRB-))) (NN ZDF) (NN control) (NNS rats))))))))))))))
-1 #(S1 (S (VP (TO To) (VP (VB determine) (SBAR (SBAR (IN whether) (S (NP (NN _PROT_)) (VP (VBZ does) (, ,) (PP (IN in) (NP (NN fact))) (, ,) (VP (VB have) (NP (NN uncoupling) (NN activity)))))) (CC and) (, ,) (SBAR (IN if) (S (ADVP (RB so)) (, ,) (SBAR (IN whether) (S (NP (JJ such) (NN activity)) (VP (MD would) (ADVP (RB favorably)) (VP (VB influence) (NP (NP (DT the) (NNS abnormalities)) (PP (IN in) (NP (NP (JJ _PROT1_) (JJ _PROT2_) (NNS islets)) (PP (IN of) (NP (JJ diabetic) (NN ZDF) (NNS rats)))))))))) (, ,) (NP (PRP we)) (VP (VBN transferred) (NP (DT the) (NN _PROT_) (NN gene)) (PP (TO to) (NP (NP (DT the) (NNS islets)) (PP (IN of) (NP (NP (JJ diabetic) (NN ZDF) (NNS rats)) (CC and) (NP (ADJP (ADJP (JJ lean)) (PRN (-LRB- -LRB-) (NP (NN +/+)) (-RRB- -RRB-))) (NN ZDF) (NN control) (NNS rats))))))))))))))
-1 #(S1 (S (VP (TO To) (VP (VB determine) (SBAR (SBAR (IN whether) (S (NP (NN _PROT_)) (VP (VBZ does) (, ,) (PP (IN in) (NP (NN fact))) (, ,) (VP (VB have) (NP (NN uncoupling) (NN activity)))))) (CC and) (, ,) (SBAR (IN if) (S (ADVP (RB so)) (, ,) (SBAR (IN whether) (S (NP (JJ such) (NN activity)) (VP (MD would) (ADVP (RB favorably)) (VP (VB influence) (NP (NP (DT the) (NNS abnormalities)) (PP (IN in) (NP (NP (JJ _PROT1_) (JJ _PROT_) (NNS islets)) (PP (IN of) (NP (JJ diabetic) (NN ZDF) (NNS rats)))))))))) (, ,) (NP (PRP we)) (VP (VBN transferred) (NP (DT the) (NN _PROT2_) (NN gene)) (PP (TO to) (NP (NP (DT the) (NNS islets)) (PP (IN of) (NP (NP (JJ diabetic) (NN ZDF) (NNS rats)) (CC and) (NP (ADJP (ADJP (JJ lean)) (PRN (-LRB- -LRB-) (NP (NN +/+)) (-RRB- -RRB-))) (NN ZDF) (NN control) (NNS rats))))))))))))))
-1 #(S1 (S (VP (TO To) (VP (VB determine) (SBAR (SBAR (IN whether) (S (NP (NN _PROT_)) (VP (VBZ does) (, ,) (PP (IN in) (NP (NN fact))) (, ,) (VP (VB have) (NP (NN uncoupling) (NN activity)))))) (CC and) (, ,) (SBAR (IN if) (S (ADVP (RB so)) (, ,) (SBAR (IN whether) (S (NP (JJ such) (NN activity)) (VP (MD would) (ADVP (RB favorably)) (VP (VB influence) (NP (NP (DT the) (NNS abnormalities)) (PP (IN in) (NP (NP (JJ _PROT_) (JJ _PROT1_) (NNS islets)) (PP (IN of) (NP (JJ diabetic) (NN ZDF) (NNS rats)))))))))) (, ,) (NP (PRP we)) (VP (VBN transferred) (NP (DT the) (NN _PROT2_) (NN gene)) (PP (TO to) (NP (NP (DT the) (NNS islets)) (PP (IN of) (NP (NP (JJ diabetic) (NN ZDF) (NNS rats)) (CC and) (NP (ADJP (ADJP (JJ lean)) (PRN (-LRB- -LRB-) (NP (NN +/+)) (-RRB- -RRB-))) (NN ZDF) (NN control) (NNS rats))))))))))))))
-1 #(S1 (S (NP (PRP We)) (VP (VBP conclude) (SBAR (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ has) (NP (NN uncoupling) (NN function)) (SBAR (WHADVP (WRB when)) (S (VP (VBN overexpressed) (PP (IN in) (NP (JJ _PROT2_) (NNS islets))))))))) (CC and) (SBAR (IN that) (S (NP (PRP$ its) (NN overexpression)) (VP (VP (VBZ corrects) (NP (NP (DT the) (NN underexpression)) (PP (IN of) (NP (DT the) (NN insulin) (NN gene))))) (CC and) (VP (VBZ ameliorates) (NP (JJ glucose-stimulated) (NN insulin) (NN secretion))) (, ,) (PP (ADVP (RB possibly)) (IN by) (S (VP (VBG increasing) (NP (DT the) (NN ATP) (: :) (NN ADP) (NN ratio))))))))))))
-1 #(S1 (S (NP (NP (DT The) (JJ second) (NN class)) (PP (IN of) (NP (NP (NN mutant)) (, ,) (NP (NP (NN gse)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_) (NN sensitivity)) (-RRB- -RRB-))) (, ,)))) (VP (VBD differed) (ADVP (RB principally)) (PP (IN in) (NP (NN _PROT2_) (NN sensitivity))) (, ,) (S (VP (VBG requiring) (NP (NP (ADJP (RB approximately) (RB 100-fold) (JJR higher)) (NN _PROT_) (-RRB- -RSB-)) (PP (IN for) (NP (CC both) (NP (NN leaf) (NN elongation)) (CC and) (NP (NN _PROT_) (NN production)))) (PP (IN by) (NP (NN aleurone)))))))))
-1 #(S1 (S (NP (NP (DT The) (JJ second) (NN class)) (PP (IN of) (NP (NP (NN mutant)) (, ,) (NP (NP (NN gse)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_) (NN sensitivity)) (-RRB- -RRB-))) (, ,)))) (VP (VBD differed) (ADVP (RB principally)) (PP (IN in) (NP (NN _PROT_) (NN sensitivity))) (, ,) (S (VP (VBG requiring) (NP (NP (ADJP (RB approximately) (RB 100-fold) (JJR higher)) (NN _PROT2_) (-RRB- -RSB-)) (PP (IN for) (NP (CC both) (NP (NN leaf) (NN elongation)) (CC and) (NP (NN _PROT_) (NN production)))) (PP (IN by) (NP (NN aleurone)))))))))
-1 #(S1 (S (NP (NP (DT The) (JJ second) (NN class)) (PP (IN of) (NP (NP (NN mutant)) (, ,) (NP (NP (NN gse)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_) (NN sensitivity)) (-RRB- -RRB-))) (, ,)))) (VP (VBD differed) (ADVP (RB principally)) (PP (IN in) (NP (NN _PROT_) (NN sensitivity))) (, ,) (S (VP (VBG requiring) (NP (NP (ADJP (RB approximately) (RB 100-fold) (JJR higher)) (NN _PROT_) (-RRB- -RSB-)) (PP (IN for) (NP (CC both) (NP (NN leaf) (NN elongation)) (CC and) (NP (NN _PROT2_) (NN production)))) (PP (IN by) (NP (NN aleurone)))))))))
-1 #(S1 (S (NP (NP (DT The) (JJ second) (NN class)) (PP (IN of) (NP (NP (NN mutant)) (, ,) (NP (NP (NN gse)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (NN sensitivity)) (-RRB- -RRB-))) (, ,)))) (VP (VBD differed) (ADVP (RB principally)) (PP (IN in) (NP (NN _PROT1_) (NN sensitivity))) (, ,) (S (VP (VBG requiring) (NP (NP (ADJP (RB approximately) (RB 100-fold) (JJR higher)) (NN _PROT2_) (-RRB- -RSB-)) (PP (IN for) (NP (CC both) (NP (NN leaf) (NN elongation)) (CC and) (NP (NN _PROT_) (NN production)))) (PP (IN by) (NP (NN aleurone)))))))))
-1 #(S1 (S (NP (NP (DT The) (JJ second) (NN class)) (PP (IN of) (NP (NP (NN mutant)) (, ,) (NP (NP (NN gse)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (NN sensitivity)) (-RRB- -RRB-))) (, ,)))) (VP (VBD differed) (ADVP (RB principally)) (PP (IN in) (NP (NN _PROT1_) (NN sensitivity))) (, ,) (S (VP (VBG requiring) (NP (NP (ADJP (RB approximately) (RB 100-fold) (JJR higher)) (NN _PROT_) (-RRB- -RSB-)) (PP (IN for) (NP (CC both) (NP (NN leaf) (NN elongation)) (CC and) (NP (NN _PROT2_) (NN production)))) (PP (IN by) (NP (NN aleurone)))))))))
+1 #(S1 (S (NP (NP (DT The) (JJ second) (NN class)) (PP (IN of) (NP (NP (NN mutant)) (, ,) (NP (NP (NN gse)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (NN sensitivity)) (-RRB- -RRB-))) (, ,)))) (VP (VBD differed) (ADVP (RB principally)) (PP (IN in) (NP (NN _PROT_) (NN sensitivity))) (, ,) (S (VP (VBG requiring) (NP (NP (ADJP (RB approximately) (RB 100-fold) (JJR higher)) (NN _PROT1_) (-RRB- -RSB-)) (PP (IN for) (NP (CC both) (NP (NN leaf) (NN elongation)) (CC and) (NP (NN _PROT2_) (NN production)))) (PP (IN by) (NP (NN aleurone)))))))))
-1 #(S1 (S (NP (NP (NP (NNS Neurotransmitters)) (CC and) (NP (NNS hormones))) (, ,) (PP (JJ such) (IN as) (NP (NP (NP (NN arginine) (NN vasopressin)) (PRN (-LRB- -LRB-) (NP (NN AVP)) (-RRB- -RRB-))) (CC and) (NP (NN bombesin)))) (, ,)) (VP (VB evoke) (NP (NP (JJ frequency-modulated) (JJ repetitive) (NN Ca2+) (NNS transients)) (PP (IN in) (NP (JJ _PROT1_) (NN HIT-T15) (NNS cells)))) (PP (IN by) (S (VP (VBG binding) (PP (TO to) (NP (NP (NNS receptors)) (VP (VBN linked) (PP (TO to) (NP (NP (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN PLC)) (-RRB- -RRB-)))))))))))))
-1 #(S1 (S (NP (NP (NP (JJ _PROT1_) (NN signaling)) (PP (IN in) (NP (NN yeast)))) (: :) (NP (NP (NN modulation)) (PP (IN of) (NP (NP (NP (NN protein) (NN phosphatase) (NN 2A)) (, ,) (NP (NN protein) (NN kinase) (NN A)) (, ,) (NP (JJ cAMP-specific) (NN phosphodiesterase)) (, ,) (CC and) (NP (JJ glycosyl-phosphatidylinositol-specific) (NN _PROT2_) (NN _PROT2_))) (NNS activities)))))))
+1 #(S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NP (JJ _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN GPI-PLC)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (PP (IN in) (NP (VBN isolated) (NN rat) (NNS adipocytes))) (VP (VBZ is) (VP (VBN activated) (PP (IN by) (NP (NN _PROT2_))))))) (, ,)) (VP (VBD was) (VP (VBN stimulated) (PP (TO to) (NP (RB up) (TO to) (RB 5-fold))) (PP (PP (IN by) (NP (NN glucose))) (CC and) (ADVP (RB 10-fold)) (PP (IN by) (NP (NP (NP (NN glucose)) (CC plus) (NP (NN _PROT_))) (PP (IN in) (NP (NP (CC both) (NP (NN yeast) (NNS spheroplasts)) (CC and) (NP (JJ intact) (NNS cells))) (VP (VBG leading) (PP (TO to) (NP (NP (DT a) (JJ concentration-dependent) (NN leftward) (NN shift)) (PP (IN of) (NP (NP (DT the) (JJ glucose-response) (NN curve)) (PP (IN for) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NN _PROT_)))))))))))))))))))
+1 #(S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NP (JJ _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN GPI-PLC)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (PP (IN in) (NP (VBN isolated) (NN rat) (NNS adipocytes))) (VP (VBZ is) (VP (VBN activated) (PP (IN by) (NP (NN _PROT_))))))) (, ,)) (VP (VBD was) (VP (VBN stimulated) (PP (TO to) (NP (RB up) (TO to) (RB 5-fold))) (PP (PP (IN by) (NP (NN glucose))) (CC and) (ADVP (RB 10-fold)) (PP (IN by) (NP (NP (NP (NN glucose)) (CC plus) (NP (NN _PROT2_))) (PP (IN in) (NP (NP (CC both) (NP (NN yeast) (NNS spheroplasts)) (CC and) (NP (JJ intact) (NNS cells))) (VP (VBG leading) (PP (TO to) (NP (NP (DT a) (JJ concentration-dependent) (NN leftward) (NN shift)) (PP (IN of) (NP (NP (DT the) (JJ glucose-response) (NN curve)) (PP (IN for) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NN _PROT_)))))))))))))))))))
-1 #(S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NP (JJ _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN GPI-PLC)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (PP (IN in) (NP (VBN isolated) (NN rat) (NNS adipocytes))) (VP (VBZ is) (VP (VBN activated) (PP (IN by) (NP (NN _PROT_))))))) (, ,)) (VP (VBD was) (VP (VBN stimulated) (PP (TO to) (NP (RB up) (TO to) (RB 5-fold))) (PP (PP (IN by) (NP (NN glucose))) (CC and) (ADVP (RB 10-fold)) (PP (IN by) (NP (NP (NP (NN glucose)) (CC plus) (NP (NN _PROT_))) (PP (IN in) (NP (NP (CC both) (NP (NN yeast) (NNS spheroplasts)) (CC and) (NP (JJ intact) (NNS cells))) (VP (VBG leading) (PP (TO to) (NP (NP (DT a) (JJ concentration-dependent) (NN leftward) (NN shift)) (PP (IN of) (NP (NP (DT the) (JJ glucose-response) (NN curve)) (PP (IN for) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NN _PROT2_)))))))))))))))))))
-1 #(S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NP (JJ _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN GPI-PLC)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (PP (IN in) (NP (VBN isolated) (NN rat) (NNS adipocytes))) (VP (VBZ is) (VP (VBN activated) (PP (IN by) (NP (NN _PROT1_))))))) (, ,)) (VP (VBD was) (VP (VBN stimulated) (PP (TO to) (NP (RB up) (TO to) (RB 5-fold))) (PP (PP (IN by) (NP (NN glucose))) (CC and) (ADVP (RB 10-fold)) (PP (IN by) (NP (NP (NP (NN glucose)) (CC plus) (NP (NN _PROT2_))) (PP (IN in) (NP (NP (CC both) (NP (NN yeast) (NNS spheroplasts)) (CC and) (NP (JJ intact) (NNS cells))) (VP (VBG leading) (PP (TO to) (NP (NP (DT a) (JJ concentration-dependent) (NN leftward) (NN shift)) (PP (IN of) (NP (NP (DT the) (JJ glucose-response) (NN curve)) (PP (IN for) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NN _PROT_)))))))))))))))))))
-1 #(S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NP (JJ _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN GPI-PLC)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (PP (IN in) (NP (VBN isolated) (NN rat) (NNS adipocytes))) (VP (VBZ is) (VP (VBN activated) (PP (IN by) (NP (NN _PROT1_))))))) (, ,)) (VP (VBD was) (VP (VBN stimulated) (PP (TO to) (NP (RB up) (TO to) (RB 5-fold))) (PP (PP (IN by) (NP (NN glucose))) (CC and) (ADVP (RB 10-fold)) (PP (IN by) (NP (NP (NP (NN glucose)) (CC plus) (NP (NN _PROT_))) (PP (IN in) (NP (NP (CC both) (NP (NN yeast) (NNS spheroplasts)) (CC and) (NP (JJ intact) (NNS cells))) (VP (VBG leading) (PP (TO to) (NP (NP (DT a) (JJ concentration-dependent) (NN leftward) (NN shift)) (PP (IN of) (NP (NP (DT the) (JJ glucose-response) (NN curve)) (PP (IN for) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NN _PROT2_)))))))))))))))))))
-1 #(S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NP (JJ _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN GPI-PLC)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (PP (IN in) (NP (VBN isolated) (NN rat) (NNS adipocytes))) (VP (VBZ is) (VP (VBN activated) (PP (IN by) (NP (NN _PROT_))))))) (, ,)) (VP (VBD was) (VP (VBN stimulated) (PP (TO to) (NP (RB up) (TO to) (RB 5-fold))) (PP (PP (IN by) (NP (NN glucose))) (CC and) (ADVP (RB 10-fold)) (PP (IN by) (NP (NP (NP (NN glucose)) (CC plus) (NP (NN _PROT1_))) (PP (IN in) (NP (NP (CC both) (NP (NN yeast) (NNS spheroplasts)) (CC and) (NP (JJ intact) (NNS cells))) (VP (VBG leading) (PP (TO to) (NP (NP (DT a) (JJ concentration-dependent) (NN leftward) (NN shift)) (PP (IN of) (NP (NP (DT the) (JJ glucose-response) (NN curve)) (PP (IN for) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NN _PROT2_)))))))))))))))))))
+1 #(S1 (S (NP (NN _PROT1_)) (VP (VBD was) (ADVP (RBS most) (RB pronouncedly)) (VP (VBN stimulated) (PP (IN by) (NP (JJ authentic) (JJ human) (NN _PROT2_))) (PP (VBN compared) (PP (TO to) (NP (NP (JJ various) (NN insulin) (NNS analogues)) (CC and) (NP (JJ insulin-like) (NN growth) (NN factor) (CD I)))))))))
-1 #(S1 (S (SBAR (IN As) (S (NP (DT the) (NN _PROT1_) (NN reaction)) (VP (VBZ is) (ADJP (NN rate) (VBG limiting))))) (, ,) (NP (NP (DT the) (NN efficiency)) (PP (IN of) (NP (DT the) (JJ two-step) (NN anchor) (NN cleavage)))) (VP (VBD was) (ADVP (RB significantly)) (VP (VBN increased)) (SBAR (WHADVP (WRB when)) (S (NP (NN _PROT2_)) (VP (VBD was) (ADJP (JJ present)) (PP (ADVP (RB together)) (IN with) (NP (NN glucose))) (SBAR (IN as) (S (VP (VBN compared) (PP (TO to) (NP (NN glucose))) (ADVP (RB alone)))))))))))
+1 #(S1 (S (NP (NP (DT The) (NN _PROT1_) (NNS concentrations)) (ADJP (JJ effective) (PP (IN in) (S (VP (VBG modulating) (NP (NP (NP (NN PP2A)) (, ,) (NP (NN PKA)) (, ,) (NP (NN cAMP-PDE)) (, ,) (CC and) (NP (NN _PROT2_))) (NNS activities))))))) (VP (VBP correlate) (ADVP (RB well)) (PP (IN with) (NP (NP (DT those)) (VP (VBN required) (PP (PP (IN for) (NP (NP (NN half-saturation)) (PP (IN of) (NP (DT the) (JJ specific) (NN binding) (NNS sites))))) (CONJP (RB as) (RB well) (IN as)) (PP (IN for) (NP (NP (NN stimulation)) (PP (IN of) (NP (NP (NN protein) (NN phosphorylation)) (CC and) (NP (NN glycogen) (NN accumulation)))))))))))))
-1 #(S1 (S (NP (DT The) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (JJ mammalian) (JJ _PROT1_) (NNS cells)) (CC and) (NP (NN yeast))) (VP (VBP share) (PRN (-LRB- -LRB-) (NP (NP (NN part)) (PP (IN of))) (-RRB- -RRB-)) (NP (NP (DT the) (JJ key) (JJ regulatory) (NN mechanism)) (-LRB- -LRB-) (VP (VBG consisting) (PP (IN of) (NP (NP (NN PP2A)) (, ,) (NP (NN PKA)) (, ,) (NP (NN cAMP-PDE)) (, ,) (CC and) (NP (NN _PROT2_))))) (-RRB- -RRB-) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN transduction)) (PP (IN of) (NP (NP (DT the) (NN _PROT_) (NN signal)) (PP (IN from) (NP (DT the) (JJ respective) (NN receptor) (NNS systems))) (PP (TO to) (NP (NP (NN glycogen) (NN synthase)) (CC and) (NP (NN phosphorylase))))))))))))))))
-1 #(S1 (S (NP (DT The) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (JJ mammalian) (JJ _PROT1_) (NNS cells)) (CC and) (NP (NN yeast))) (VP (VBP share) (PRN (-LRB- -LRB-) (NP (NP (NN part)) (PP (IN of))) (-RRB- -RRB-)) (NP (NP (DT the) (JJ key) (JJ regulatory) (NN mechanism)) (-LRB- -LRB-) (VP (VBG consisting) (PP (IN of) (NP (NP (NN PP2A)) (, ,) (NP (NN PKA)) (, ,) (NP (NN cAMP-PDE)) (, ,) (CC and) (NP (NN _PROT_))))) (-RRB- -RRB-) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN transduction)) (PP (IN of) (NP (NP (DT the) (NN _PROT2_) (NN signal)) (PP (IN from) (NP (DT the) (JJ respective) (NN receptor) (NNS systems))) (PP (TO to) (NP (NP (NN glycogen) (NN synthase)) (CC and) (NP (NN phosphorylase))))))))))))))))
+1 #(S1 (S (NP (DT The) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (JJ mammalian) (JJ _PROT_) (NNS cells)) (CC and) (NP (NN yeast))) (VP (VBP share) (PRN (-LRB- -LRB-) (NP (NP (NN part)) (PP (IN of))) (-RRB- -RRB-)) (NP (NP (DT the) (JJ key) (JJ regulatory) (NN mechanism)) (-LRB- -LRB-) (VP (VBG consisting) (PP (IN of) (NP (NP (NN PP2A)) (, ,) (NP (NN PKA)) (, ,) (NP (NN cAMP-PDE)) (, ,) (CC and) (NP (NN _PROT1_))))) (-RRB- -RRB-) (VP (VBN involved) (PP (IN in) (NP (NP (DT the) (NN transduction)) (PP (IN of) (NP (NP (DT the) (NN _PROT2_) (NN signal)) (PP (IN from) (NP (DT the) (JJ respective) (NN receptor) (NNS systems))) (PP (TO to) (NP (NP (NN glycogen) (NN synthase)) (CC and) (NP (NN phosphorylase))))))))))))))))
+1 #(S1 (S (NP (NP (DT The) (ADJP (NN glycosyl-phosphatidylinositol) (VBN anchored)) (NN protein)) (, ,) (NP (NP (NN membrane) (NN dipeptidase)) (PRN (-LRB- -LRB-) (NP (NN EC) (CD 3.4.13.19)) (-RRB- -RRB-)))) (VP (VBZ is) (VP (VBN released) (PP (IN from) (NP (NP (DT the) (NN surface)) (PP (IN of) (NP (NN 3T3-L1) (NNS adipocytes))))) (PP (IN in) (NN response) (TO to) (NP (NN _PROT1_) (NN treatment))) (PP (IN through) (NP (NP (DT the) (NN action)) (PP (IN of) (NP (DT a) (NN _PROT2_) (NN _PROT2_)))))))))
-1 #(S1 (S (SBAR (IN Although) (S (NP (NP (NN X-Pro) (NN aminopeptidase)) (PRN (-LRB- -LRB-) (NP (NN EC) (CD 3.4.11.9)) (-RRB- -RRB-))) (VP (VBZ is) (ADJP (JJ GPI-anchored)) (PP (IN in) (NP (NN 3T3-L1) (NNS adipocytes))) (SBAR (IN as) (S (VP (VBN shown) (PP (IN by) (NP (NP (NN digestion)) (PP (IN with) (NP (JJ bacterial) (JJ phosphatidylinositol-specific) (NN _PROT1_) (NN _PROT1_))))))))))) (, ,) (S (NP (PRP it)) (VP (VBD was) (RB not) (VP (VBN released) (PP (IN upon) (NP (NP (NN _PROT2_) (NN treatment)) (PP (IN of) (NP (DT the) (NNS cells)))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (RB only) (DT a) (NN subset)) (PP (IN of) (NP (DT the) (JJ GPI-anchored) (NNS proteins)))) (VP (VBP are) (ADJP (JJ susceptible) (PP (TO to) (NP (JJ _PROT_) (NN release)))))))))))))
-1 #(S1 (S (SBAR (IN Although) (S (NP (NP (NN X-Pro) (NN aminopeptidase)) (PRN (-LRB- -LRB-) (NP (NN EC) (CD 3.4.11.9)) (-RRB- -RRB-))) (VP (VBZ is) (ADJP (JJ GPI-anchored)) (PP (IN in) (NP (NN 3T3-L1) (NNS adipocytes))) (SBAR (IN as) (S (VP (VBN shown) (PP (IN by) (NP (NP (NN digestion)) (PP (IN with) (NP (JJ bacterial) (JJ phosphatidylinositol-specific) (NN _PROT1_) (NN _PROT1_))))))))))) (, ,) (S (NP (PRP it)) (VP (VBD was) (RB not) (VP (VBN released) (PP (IN upon) (NP (NP (NN _PROT_) (NN treatment)) (PP (IN of) (NP (DT the) (NNS cells)))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (RB only) (DT a) (NN subset)) (PP (IN of) (NP (DT the) (JJ GPI-anchored) (NNS proteins)))) (VP (VBP are) (ADJP (JJ susceptible) (PP (TO to) (NP (JJ _PROT2_) (NN release)))))))))))))
-1 #(S1 (S (SBAR (IN Although) (S (NP (NP (NN X-Pro) (NN aminopeptidase)) (PRN (-LRB- -LRB-) (NP (NN EC) (CD 3.4.11.9)) (-RRB- -RRB-))) (VP (VBZ is) (ADJP (JJ GPI-anchored)) (PP (IN in) (NP (NN 3T3-L1) (NNS adipocytes))) (SBAR (IN as) (S (VP (VBN shown) (PP (IN by) (NP (NP (NN digestion)) (PP (IN with) (NP (JJ bacterial) (JJ phosphatidylinositol-specific) (NN _PROT_) (NN _PROT_))))))))))) (, ,) (S (NP (PRP it)) (VP (VBD was) (RB not) (VP (VBN released) (PP (IN upon) (NP (NP (NN _PROT1_) (NN treatment)) (PP (IN of) (NP (DT the) (NNS cells)))))) (, ,) (S (VP (VBG indicating) (SBAR (IN that) (S (NP (NP (RB only) (DT a) (NN subset)) (PP (IN of) (NP (DT the) (JJ GPI-anchored) (NNS proteins)))) (VP (VBP are) (ADJP (JJ susceptible) (PP (TO to) (NP (JJ _PROT2_) (NN release)))))))))))))
-1 #(S1 (S (NP (PRP We)) (VP (VBP have) (VP (VBN established) (SBAR (IN that) (S (NP (NP (DT the) (NN recovery)) (PP (IN of) (NP (VBN secreted) (NN _PROT1_)))) (VP (VBZ is) (VP (VBN increased) (PP (IN by) (NP (NP (DT the) (NP (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (NNS agonists)) (NP (NP (NN PDBu)) (CC and) (NP (NN PMA))))) (PP (IN in) (NP (DT a) (ADJP (ADJP (NN time-)) (CC and) (ADJP (JJ dose-dependent))) (NN manner))) (PP (IN in) (NP (DT both) (NN cell) (NNS lines)))))))))))
-1 #(S1 (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (NN secretion)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ remains) (VP (VBN unaffected) (PP (PP (IN by) (NP (DT the) (JJ inactive) (NN PDBu) (NN analog) (NN alphaPDD))) (CC and) (PP (IN by) (NP (NP (DT the) (NP (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (NNS effectors)) (NP (NP (NN dibutyryl) (NN cAMP)) (CC and) (NP (NN forskolin))))))))))
+1 #(S1 (S (ADVP (RB Overall)) (, ,) (NP (PRP$ our) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (DT the) (JJ normal) (NN processing)) (PP (IN of) (NP (NP (NN _PROT1_)) (PRN (-LRB- _PROT1_) (NP (NN _PROT1_)) (-RRB- _PROT1_))))) (VP (VBZ is) (VP (VBN up-regulated) (PP (IN by) (NP (NP (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (CONJP (CC but) (RB not)) (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)))) (PP (IN in) (NP (NP (JJ human) (NNS cells)) (CC and) (NP (JJ murine) (NNS neurons)))))))))))
-1 #(S1 (S (ADVP (RB Overall)) (, ,) (NP (PRP$ our) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (DT the) (JJ normal) (NN processing)) (PP (IN of) (NP (NP (NN _PROT1_)) (PRN (-LRB- _PROT1_) (NP (NN _PROT1_)) (-RRB- _PROT1_))))) (VP (VBZ is) (VP (VBN up-regulated) (PP (IN by) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (CONJP (CC but) (RB not)) (NP (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)))) (PP (IN in) (NP (NP (JJ human) (NNS cells)) (CC and) (NP (JJ murine) (NNS neurons)))))))))))
-1 #(S1 (S (ADVP (RB Overall)) (, ,) (NP (PRP$ our) (NNS data)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NP (DT the) (JJ normal) (NN processing)) (PP (IN of) (NP (NP (NN _PROT_)) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_))))) (VP (VBZ is) (VP (VBN up-regulated) (PP (IN by) (NP (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (CONJP (CC but) (RB not)) (NP (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)))) (PP (IN in) (NP (NP (JJ human) (NNS cells)) (CC and) (NP (JJ murine) (NNS neurons)))))))))))
+1 #(S1 (S (NP (NP (DT A) (JJ caveolin-1-dependent) (NN coupling)) (PP (IN of) (NP (NN _PROT1_))) (PP (TO to) (NP (DT the) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)))) (VP (VBD was) (VP (VBN observed)))))
+1 #(S1 (S (ADVP (RB Recently)) (NP (JJ several) (JJ significant) (NNS advances)) (VP (VBP have) (VP (VBN been) (VP (VBN made) (PP (IN in) (NP (DT this) (NN area))) (, ,) (PP (VBG including) (NP (NP (NP (DT the) (NN identification)) (PP (IN of) (NP (NP (DT the) (JJ appetite) (NN regulating) (NN hormone)) (, ,) (NP (NN _PROT1_)) (, ,)))) (CC and) (NP (NP (DT a) (JJ detailed) (NN understanding)) (PP (IN of) (NP (NP (PRP$ its) (NNS targets)) (PP (IN in) (NP (NP (DT the) (JJ central) (JJ nervous) (NN system)) (PRN (-LRB- -LRB-) (NP (NN CNS)) (-RRB- -RRB-)))) (, ,) (PP (JJ such) (IN as) (NP (NP (NP (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN NPY)) (-RRB- -RRB-))) (CC and) (NP (DT the) (NN melanocortin-4) (NN receptor))))))))))))))
+1 #(S1 (S (NP (NP (NP (NN Activity)) (CC and) (NP (NN expression))) (PP (IN of) (NP (DT the) (CD three) (NN _PROT1_) (NNS 's)))) (VP (VBP are) (VP (VBN stimulated) (PP (IN by) (NP (NP (NP (JJ several) (NNS neuromediators)) (CC and) (NP (NNS hormones))) (PP (JJ such) (IN as) (NP (NP (NN noradrenaline)) (, ,) (NP (NN tri-iodothyronine)) (CC and) (NP (NN _PROT2_))))))))))
